Current strategy for local- to global-level molecular epidemiological characterisation of global antimicrobial resistance surveillance system pathogens

Indian J Med Microbiol. 2019 Apr-Jun;37(2):147-162. doi: 10.4103/ijmm.IJMM_19_396.

Abstract

The prime goal of molecular epidemiology is to identify the origin and evolution of pathogens, which can potentially influence the public health worldwide. Traditional methods provide limited information which is not sufficient for outbreak investigation and studying transmission dynamics. The recent advancement of next-generation sequencing had a major impact on molecular epidemiological studies. Currently, whole-genome sequencing (WGS) has become the gold standard typing method, especially for clinically significant pathogens. Here, we aimed to describe the application of appropriate molecular typing methods for global antimicrobial resistance surveillance system pathogens based on the level of discrimination and epidemiological settings. This shows that sequence-based methods such as multi-locus sequence typing (MLST) are widely used due to cost-effectiveness and database accessibility. However, WGS is the only method of choice for studying Escherichia coli and Shigella spp. WGS is shown to have higher discrimination than other methods in typing Klebsiella pneumoniae, Acinetobacter baumannii and Salmonella spp. due to its changing accessory genome content. For Gram positives such as Streptococcus pneumoniae, WGS would be preferable to understand the evolution of the strains. Similarly, for Staphylococcus aureus, combination of MLST, staphylococcal protein A or SCCmec typing along with WGS could be the choice for epidemiological typing of hospital- and community-acquired strains. This review highlights that combinations of different typing methods should be used to get complete information since no one standalone method is sufficient to study the varying genome diversity.

Keywords: Antimicrobial resistance lineages; global antimicrobial resistance surveillance system; molecular epidemiology; outbreak investigation; whole genome sequencing.

MeSH terms

  • Anti-Infective Agents* / pharmacology
  • Anti-Infective Agents* / therapeutic use
  • Communicable Diseases / drug therapy
  • Communicable Diseases / epidemiology*
  • Communicable Diseases / etiology*
  • Communicable Diseases / transmission
  • Disease Outbreaks
  • Drug Resistance, Microbial*
  • Geography
  • Global Health
  • Humans
  • Molecular Epidemiology
  • Molecular Typing / methods
  • Population Surveillance
  • Whole Genome Sequencing

Substances

  • Anti-Infective Agents